GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle.

Saved in:
Bibliographic Details
Title: GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle.
Authors: Marcotte GR; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; University of Iowa, Iowa City, Iowa, USA., Miller MJ; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; University of Iowa, Iowa City, Iowa, USA., Kunz HE; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ryan ZC; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Strub MD; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Vanderboom PM; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Heppelmann CJ; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Chau S; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Von Ruff ZD; University of Texas Medical Branch, Galveston, Texas, USA., Kilroe SP; University of Texas Medical Branch, Galveston, Texas, USA., McKeen AT; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; University of Iowa, Iowa City, Iowa, USA., Dierdorff JM; University of Iowa, Iowa City, Iowa, USA., Stern JI; Department of Neurology and., Nath KA; Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Grueter CE; University of Iowa, Iowa City, Iowa, USA., Lira VA; University of Iowa, Iowa City, Iowa, USA., Judge AR; University of Florida, Gainesville, Florida, USA.; Emmyon, Inc., Rochester, Minnesota, USA., Rasmussen BB; University of Texas Medical Branch, Galveston, Texas, USA.; Emmyon, Inc., Rochester, Minnesota, USA.; University of Texas Health Science Center, San Antonio, Texas, USA., Nair KS; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Lanza IR; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ebert SM; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Emmyon, Inc., Rochester, Minnesota, USA., Adams CM; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Emmyon, Inc., Rochester, Minnesota, USA.
Source: JCI insight [JCI Insight] 2023 Nov 22; Vol. 8 (22). Date of Electronic Publication: 2023 Nov 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.171772